10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001035267-19-000139`
Period End Date	20190930
Filing Date	20191018
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	isrg-20190930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 72 Cash Flow Statement 68

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$857.90M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$969.60M	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.21B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$1.93B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$682.30M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$639.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$579.60M	USD	Point-in-time
Inventory	`InventoryNet`	$409.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	115.60M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.50M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$178.80M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$200.80M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.32B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	115.60M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.33B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$812.00M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.14B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.53B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.77B	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$428.60M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$424.10M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$261.00M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$415.70M	USD	Point-in-time
Goodwill	`Goodwill`	$240.60M	USD	Point-in-time
Goodwill	`Goodwill`	$304.70M	USD	Point-in-time
Total assets	`Assets`	$7.85B	USD	Point-in-time
Total assets	`Assets`	$9.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$132.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.70M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$187.40M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$193.80M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$294.30M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$307.60M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$231.80M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$303.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$930.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$820.60M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$338.60M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$423.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.35B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.16B	USD	Point-in-time
Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September 30, 2019, and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of September 30, 2019, and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 115.6 shares and 114.5 shares issued and outstanding as of September 30, 2019, and December 31, 2018, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 115.6 shares and 114.5 shares issued and outstanding as of September 30, 2019, and December 31, 2018, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.17B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.60B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.52B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.14B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.50M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.10M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.70M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-13.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$17.80M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.40M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$6.68B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$7.76B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$8.70M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$15.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.87B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.69B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.28B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.13B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$7.85B	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.68B	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$920.90M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.20B	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.13B	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$809.30M	USD	3 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$278.60M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$342.60M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$986.60M	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.87B	USD	3 Qtrs
Gross profit	`GrossProfit`	$642.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.21B	USD	3 Qtrs
Gross profit	`GrossProfit`	$785.60M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$284.00M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$221.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$836.60M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$702.80M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$135.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$400.70M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$107.60M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$298.20M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.00B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$329.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$419.90M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.24B	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$313.30M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$365.70M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$976.90M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$867.40M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$21.90M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$53.30M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$93.60M	USD	3 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$33.30M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$920.70M	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$335.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.07B	USD	3 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$399.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$87.00M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$51.40M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$43.40M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$300.00K	USD	1 Quarter
Net income	`ProfitLoss`	$398.70M	USD	1 Quarter
Net income	`ProfitLoss`	$1.02B	USD	3 Qtrs
Net income	`ProfitLoss`	$833.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$291.80M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.70M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.90M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.50M	USD	3 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-700.00K	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$835.40M	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$1.02B	USD	3 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$396.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$292.50M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$7.37	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$8.86	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.57	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.44	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.04	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$8.56	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.33	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.45	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	114.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.30M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.40M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.40M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.60M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.40M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.20M	shares	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$1.05B	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$834.20M	USD	3 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$292.20M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$398.50M	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$833.70M	USD	3 Qtrs
Net income	`ProfitLoss`	$291.80M	USD	1 Quarter
Net income	`ProfitLoss`	$398.70M	USD	1 Quarter
Net income	`ProfitLoss`	$1.02B	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$76.80M	USD	3 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$108.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$9.70M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$31.20M	USD	3 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.20M	USD	3 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$6.60M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.30M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-8.30M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$190.80M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$246.60M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$9.20M	USD	3 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$7.90M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-50.60M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$65.20M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$205.80M	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$293.40M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$95.10M	USD	3 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$89.30M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$24.70M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$13.40M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-21.50M	USD	3 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-6.80M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$5.80M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$34.70M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-39.50M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-9.20M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.05B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$831.50M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$2.54B	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.69B	USD	3 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$82.10M	USD	3 Qtrs
Proceeds from Sale of Investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$274.00M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.03B	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.05B	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$283.60M	USD	3 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$131.90M	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$31.80M	USD	3 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$60.10M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-563.30M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-748.20M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$205.70M	USD	3 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$199.60M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$115.00M	USD	3 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$152.90M	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$269.50M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$8.00M	USD	3 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$10.00M	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	3 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-12.50M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-219.20M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$92.60M	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-700.00K	USD	3 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-2.90M	USD	3 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$360.10M	USD	3 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$75.20M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.02B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$984.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.02B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$984.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.